The Cancer Stem Cells Market size was valued at USD 1315.70 Million in 2023 and the total Cancer Stem Cells revenue is expected to grow at a CAGR of 9.40% from 2024 to 2030, reaching nearly USD 2467.63 Million. The global Cancer Stem Cells market report is a comprehensive analysis of the industry, market, and key players. The report has covered the market by demand and supply-side by segments. The global Cancer Stem Cells report also provides trends by market segments, technology, and investment with a competitive landscape.To know about the Research Methodology :- Request Free Sample Report
Cancer Stem Cells Market Overview:
Cancer stem cells (CSCs), also known as tumor-initiating cells (TICs), are self-renewing cells that can repair themselves. Acute myeloid leukemia, as well as breast and central nervous system tumors, have been shown to contain cancer stem cells. Cancer stem cells can play a unique role in tumor metastasis, and understanding them could lead to the production of predictive and prognostic markers as well as targeted therapeutic interventions. Chemotherapy-resistant cancer stem cells are considered to result in a bad clinical outcome. Stem cells have been successfully used in immuno-reconstitution and blood replenishment following tumor formation or treatment over the past several years. Furthermore, these cells have attracted a lot of interest from healthcare organizations because they can be used to deliver anti-cancer drugs and regenerate tissue. According to World Health Organization (WHO) cancer is the first or second leading cause of death before the age of 70 in 112 of 183 countries in 2021, and third or fourth in another 23 countries. The rise of cancer as a leading cause of death is partially due to significant decreases in stroke and coronary heart disease mortality rates in many countries when compared to cancer.Cancer Stem Cells Market Dynamics:
Drivers:
The rapid acceptance of stem cells by healthcare professionals for tissue regeneration and as methods for anti-cancer drug delivery is propelling the cancer stem cells market forward. The use of stem cells for tumor treatment has been reported to be effective by healthcare professionals all over the world. Impact of increased public-private investment, public awareness of product therapeutic power, and the creation of a regulatory structure for stem cell therapeutics are fueling market growth while limiting tumor growth. The requirement for CSC therapy supply has increased as the number of FDA approvals for stem cell therapy has grown. The rising prevalence of chronic diseases, as well as a large number of stem cell beneficiaries, are driving the market ahead.Restraints:
The high cost of stem cell therapy treatment and stringent international healthcare agency regulations for the use of stem cell therapy, on the other hand, are impeding the development of the cancer stem cells industry.Cancer Stem Cells Market Segment Analysis:
Based on Type, the Cancer Stem Cell Market is fragmented into sub-segments such as Cell Culturing, Cell Separation, Cell Analysis, and Molecular Analysis. Among them, the Cell Culturing Sub-segment is expected to dominate the market during the forecast period. Based on Application, the Breast Cancer Diagnosis and treatment sub-segment is expected to grow at the highest pace owing to increased cases of Breast cancer worldwide followed by lung cancer. Every year, it affects 2.1 million people, and according to the WHO, 627,000 women die from it, accounting for roughly 15% of all cancer deaths among women.Cancer Stem Cells Market Regional Insights:
North America dominated the global cancer stem cell market in 2023. The demand for cancer stem cells in North America is expected to rise at a significant pace in the coming years. The availability of state-of-the-art infrastructure for medical research, the participation of a large number of organizations involved in stem cell therapy research and development as well as advances in medical research, are driving the growth of the cancer stem cells market in the area. The American Government is a significant contributor, with major consulting firms and market vendors based in the country. Multiple pipeline developments in the area are driving up consumer demand. Cancer stem cells might see rapid growth in the Asia Pacific region, owing to the involvement of many organizations focused on stem cell research and development. Furthermore, funding agencies are offering grants to research groups in Asian countries to help them accelerate their clinical research on cancer stem cells. Latin America, on the other hand, will rise at a modest pace in the coming years. In the coming years, development in the Middle East and Africa would be slower. In 2020, an estimated 19.3 million new cancer cases (18.1 million excluding nonmelanoma skin cancer) will be diagnosed worldwide, with almost 10.0 million cancer deaths (9.9 million excluding nonmelanoma skin cancer). Female breast cancer (2.26 million cases), lung (2.21), and prostate cancer (1.41 million cases) were the most frequently diagnosed cancers worldwide; lung (1.79 million deaths), liver (830000), and stomach cancers were the most common causes of cancer death (769000). The objective of the report is to present a comprehensive analysis of the global market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the global market dynamics, structure by analyzing the market segments and project the global market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the global market make the report investor’s guide.Cancer Stem Cells Market Key Developments:
Tel Aviv University researchers recently unveiled an innovative biosensor that can kill leukemic cells. The researchers want to reduce the rate of blood cancer relapse by focusing on the most malignant leukemic stem cells. Meanwhile, stem cell research is a rapidly growing medical field in Turkey, which is now known as Europe's "big star in stem cell."Cancer Stem Cells Market Scope: Inquire before buying
Cancer Stem Cells Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: USD 1315.70 Mn. Forecast Period 2024 to 2030 CAGR: 9.40% Market Size in 2030: USD 2467.63 Mn. Segments Covered: by Type Cell Culturing Cell Separation Cell Analysis Molecular Analysis Others by Application Breast Cancer Diagnosis and Treatment Prostate Cancer Diagnosis and Treatment Colorectal Cancer Diagnosis and Treatment Lung Cancer Diagnosis and Treatment Others Cancer Stem Cells Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Cancer Stem Cells Market, Key Players
1. Thermo Fisher Scientific, Inc. 2. Abbvie, Inc. 3. Merck KGaA 4. Bionomics 5. Lonza 6. Stemline Therapeutics, Inc. 7. Biotime, Inc. 8. Sino Biological 9. Irvine Scientific 10. Oncomed Pharmaceuticals, Inc. 11. Stemcell Technologies, Inc. 12. Macrogenics, Inc. 13. Miltenyi Biotec 14. Other Key Players Frequently Asked Questions: 1. Which region has the largest share in Global Cancer Stem Cells Market? Ans: North America region holds the highest share in 2023. 2. What was the Global Cancer Stem Cells Market size in 2023? Ans: The Global Cancer Stem Cells Market size was USD 1315.70 Million in 2023. 3. What is scope of the Global Cancer Stem Cells market report? Ans: Global Cancer Stem Cells Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Cancer Stem Cells market? Ans: The important key players in the Global Cancer Stem Cells Market are – Thermo Fisher Scientific, Inc., Abbvie, Inc., Merck KGaA, Bionomics, Lonza, Stemline Therapeutics, Inc., Biotime, Inc., Sino Biological, Irvine Scientific, Oncomed Pharmaceuticals, Inc., Stemcell Technologies, Inc., Macrogenics, Inc., Miltenyi Biotec, and Other Key Players. 5. What is the study period of this market? Ans: The Global Cancer Stem Cells Market is studied from 2023 to 2030.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Cancer Stem Cells Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2021 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Cancer Stem Cells Market 3.4. Geographical Snapshot of the Cancer Stem Cells Market, By Manufacturer share 4. Global Cancer Stem Cells Market Overview, 2023-2030 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Cancer Stem Cells Market 5. Supply Side and Demand Side Indicators 6. Global Cancer Stem Cells Market Analysis and Forecast, 2023-2030 6.1. Global Cancer Stem Cells Market Size & Y-o-Y Growth Analysis. 7. Global Cancer Stem Cells Market Analysis and Forecasts, 2023-2030 7.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 7.1.1. Cell Culturing 7.1.2. Cell Separation 7.1.3. Cell Analysis 7.1.4. Molecular Analysis 7.1.5. Others 7.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 7.2.1. Breast Cancer Diagnosis and Treatment 7.2.2. Prostate Cancer Diagnosis and Treatment 7.2.3. Colorectal Cancer Diagnosis and Treatment 7.2.4. Lung Cancer Diagnosis and Treatment 7.2.5. Others 8. Global Cancer Stem Cells Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2023-2030 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Cancer Stem Cells Market Analysis and Forecasts, 2023-2030 9.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 9.1.1. Cell Culturing 9.1.2. Cell Separation 9.1.3. Cell Analysis 9.1.4. Molecular Analysis 9.1.5. Others 9.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 9.2.1. Breast Cancer Diagnosis and Treatment 9.2.2. Prostate Cancer Diagnosis and Treatment 9.2.3. Colorectal Cancer Diagnosis and Treatment 9.2.4. Lung Cancer Diagnosis and Treatment 9.2.5. Others 10. North America Cancer Stem Cells Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2023-2030 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Cancer Stem Cells Market Analysis and Forecasts, 2023-2030 11.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 11.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 12. Canada Cancer Stem Cells Market Analysis and Forecasts, 2023-2030 12.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 12.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 13. Mexico Cancer Stem Cells Market Analysis and Forecasts, 2023-2030 13.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 13.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 14. Europe Cancer Stem Cells Market Analysis and Forecasts, 2023-2030 14.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 14.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 15. Europe Cancer Stem Cells Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2023-2030 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Cancer Stem Cells Market Analysis and Forecasts, 2023-2030 16.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 16.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 17. France Cancer Stem Cells Market Analysis and Forecasts, 2023-2030 17.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 17.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 18. Germany Cancer Stem Cells Market Analysis and Forecasts, 2023-2030 18.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 18.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 19. Italy Cancer Stem Cells Market Analysis and Forecasts, 2023-2030 19.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 19.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 20. Spain Cancer Stem Cells Market Analysis and Forecasts, 2023-2030 20.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 20.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 21. Sweden Cancer Stem Cells Market Analysis and Forecasts, 2023-2030 21.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 21.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 22. CIS Countries Cancer Stem Cells Market Analysis and Forecasts, 2023-2030 22.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 22.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 23. Rest of Europe Cancer Stem Cells Market Analysis and Forecasts, 2023-2030 23.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 23.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 24. Asia Pacific Cancer Stem Cells Market Analysis and Forecasts, 2023-2030 24.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 24.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 25. Asia Pacific Cancer Stem Cells Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2023-2030 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Cancer Stem Cells Market Analysis and Forecasts, 2023-2030 26.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 26.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 27. India Cancer Stem Cells Market Analysis and Forecasts, 2023-2030 27.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 27.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 28. Japan Cancer Stem Cells Market Analysis and Forecasts, 2023-2030 28.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 28.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 29. South Korea Cancer Stem Cells Market Analysis and Forecasts, 2023-2030 29.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 29.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 30. Australia Cancer Stem Cells Market Analysis and Forecasts, 2023-2030 30.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 30.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 31. ASEAN Cancer Stem Cells Market Analysis and Forecasts, 2023-2030 31.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 31.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 32. Rest of Asia Pacific Cancer Stem Cells Market Analysis and Forecasts, 2023-2030 32.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 32.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 33. Middle East Africa Cancer Stem Cells Market Analysis and Forecasts, 2023-2030 33.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 33.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 34. Middle East Africa Cancer Stem Cells Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2023-2030 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Cancer Stem Cells Market Analysis and Forecasts, 2023-2030 35.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 35.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 36. GCC Countries Cancer Stem Cells Market Analysis and Forecasts, 2023-2030 36.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 36.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 37. Egypt Cancer Stem Cells Market Analysis and Forecasts, 2023-2030 37.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 37.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 38. Nigeria Cancer Stem Cells Market Analysis and Forecasts, 2023-2030 38.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 38.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 39. Rest of ME&A Cancer Stem Cells Market Analysis and Forecasts, 2023-2030 39.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 39.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 40. South America Cancer Stem Cells Market Analysis and Forecasts, 2023-2030 40.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 40.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 41. South America Cancer Stem Cells Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2023-2030 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Cancer Stem Cells Market Analysis and Forecasts, 2023-2030 42.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 42.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 43. Argentina Cancer Stem Cells Market Analysis and Forecasts, 2023-2030 43.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 43.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 44. Rest of South America Cancer Stem Cells Market Analysis and Forecasts, 2023-2030 44.1. Market Size (Value) Estimates & Forecast By Type, 2023-2030 44.2. Market Size (Value) Estimates & Forecast By Application, 2023-2030 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Cancer Stem Cells Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile: Key Players 45.3.1. Thermo Fisher Scientific, Inc. 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Abbvie, Inc. 45.3.3. Merck KGaA 45.3.4. Bionomics 45.3.5. Lonza 45.3.6. Stemline Therapeutics, Inc. 45.3.7. Biotime, Inc. 45.3.8. Sino Biological 45.3.9. Irvine Scientific 45.3.10. Oncomed Pharmaceuticals, Inc. 45.3.11. Stemcell Technologies, Inc. 45.3.12. Macrogenics, Inc. 45.3.13. Miltenyi Biotec 45.3.14. Other Key Players 46. Primary Key Insights
